Over 537 million people globally suffer from diabetes, with 227 million in Asia Pacific. More than half may develop diabetic ...

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today ...

Updates on commercial insights and readiness plans for sozinibercept in wet AMD Opthea management to present in New York City on Tuesday, January 28 at 1:30 PM ET In-person events in Sydney on ...

The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

In September, ONL announced the closing of a $65 million Series D financing round, led by Johnson & Johnson Innovation – JJDC, Inc. The Series D funding supports the advancement of the development of ...

Worldwide, age-related macular degeneration (AMD) is the leading cause of severe ... People who have wet AMD can also experience other problems resulting from these vision issues. For example, people ...

Some people do not lose their vision from macular degeneration, while others experience vision loss soon after they ... 2013.6636 Moorfields Eye Hospital NHS Foundation Trust. Patient information anti ...

The national patient experience surveys ask service users if they feel involved in decisions about their care, the responses to which we explore here. The Adult Inpatient Survey has not been included ...

There are many benefits that can accrue from a trusting relationship, including open and honest communication of information, improved adherence to medical advice, improvement of health outcomes and ...

You might develop blurry vision or other trouble seeing. This could be a sign of age-related macular degeneration (AMD). Wet AMD is the advanced form of the disease. It happens when new blood ...

and photoreceptor integrity in patients with neovascular age-related macular degeneration (nAMD). Methods This prospective study enrolled treatment-naïve nAMD eyes and conducted a 3-month follow-up.

People who develop macular degeneration often begin experiencing symptoms after 50 years old, but symptoms can happen earlier or later depending on conditions and risk factors. Share on Pinterest ...